Search Within

Christopher A Klebanoff

Formats
  1. Journal Article (29)
  2. Meeting Abstract (19)
  3. Editorial (5)
  4. Review (4)
  5. Research Letter (2)
Groups
  1. Breast Medicine Service (59)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (59)
  3. Department of Medicine (59)
  4. GSK Faculty (59)
  5. Hematologic Malignancies, Division of (59)
  6. Human Oncology and Pathogenesis Program (59)

More Groups

People
  1. Smita Chandran (16)
  2. Inaki Etxeberria (9)
  3. Jedd Wolchok (5)
  4. David Scheinberg (4)
  5. Fei Yi (4)
  6. Martin Klatt (4)

More People

Years
  1. 2025 (8)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Journal for ImmunoTherapy of Cancer (4)
  3. Cancer Immunology Research (3)
  4. Cell (3)
  5. Nature (3)
  6. Nature Medicine (3)

More Publications

Publishers
  1. Nature Publishing Group (14)
  2. American Society of Clinical Oncology (7)
  3. Biomed Central Ltd (7)
  4. American Association for Cancer Research (6)
  5. Cell Press (6)
  6. American Association for the Advancement of Science (3)

More Publishers

Results (59)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors
    Journal Article

    James, S. E.; Chen, S.; Ng, B. D.; Fischman, J. S.; Jahn, L.; Boardman, A. P.; Rajagopalan, A.; Elias, H. K.; Massa, A.; Manuele, D.; more...
    Nature Biomedical Engineering (2024)

    Fulltext@MSK | Save
  • Loss of heterozygosity is low for specific HLA alleles in cancer patients with driver mutations
    Meeting Abstract

    Roy, C.; Sewastianik, T.; Halvey, P.; Montesion, M.; Jindal, A.; Vallaster, M.; Lam, H.; Garrity, S.; Shapiro, G.; Klebanoff, C. A.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • THRIVE(TM) non-viral targeted transgene knock-in platform generates specific and potent TCR T cell products for the treatment of solid cancers
    Meeting Abstract

    Narayan, S.; Swanson, N.; Drain, A.; Gareau, K.; Rouillard, N.; Liang, J.; Liu, H. W.; Brown, L.; Lamothe, R.; Greenberg, P. D.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • Correlation of allele-specific HLA loss of heterozygosity in patients with cancer with driver mutations
    Meeting Abstract

    Sewastianik, T.; Roy, C.; Halvey, P.; Montesion, M.; Jindal, A.; Garrity, S.; Lam, H.; Shapiro, G.; Vallaster, M. P.; Vincent, L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Public tumor-wide neoantigens derived from clonal aberrant splicing events drive tumor-specific T-cell responses
    Meeting Abstract

    Kwok, D.; Stevers, N.; Nejo, T.; Jung, J.; Chen, L.; Lakshmanachetty, S.; Etxeberria, I.; Gallus, M.; Yamamichi, A.; Ramos, E.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • T cell receptor therapeutics: Immunological targeting of the intracellular cancer proteome
    Review

    Klebanoff, C. A.; Chandran, S. S.; Baker, B. M.; Quezada, S. A.; Ribas, A.
    Nature Reviews Drug Discovery (2023)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial
    Journal Article

    Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Perspectives in immunotherapy: Meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
    Editorial

    Ascierto, P. A.; Avallone, A.; Bifulco, C.; Bracarda, S.; Brody, J. D.; Emens, L. A.; Ferris, R. L.; Formenti, S. C.; Hamid, O.; Johnson, D. B.; more...
    Journal of Translational Medicine (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Immunogenic landscape and therapeutic targeting of mutant NRAS "public" neoantigens
    Meeting Abstract

    Etxeberria, I.; Banks, L.; Chandran, S.; Correa, A.; Novak, B.; Fleischman, J.; Drilon, A.; Wolchok, J.; Merghoub, T.; Klebanoff, C.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save